Phytocosmeceutical formulation development, characterization and its in-vivo investigations

Biomed Pharmacother. 2018 Nov:107:806-817. doi: 10.1016/j.biopha.2018.08.024. Epub 2018 Aug 22.

Abstract

Several plants found rich in flavonoid, polyphenols, and antioxidants reported antiaging, oppose inflammation and carcinogenic properties but have rarely been applied in dermatology. The present study was an active attempt to formulate a stable phytocosmetic emulsion system loaded with 2% pre-concentrated Prosopis cineraria bark extract, aiming to revive facial skin properties. In order to obtain potent therapeutic activities, we first prepared extracts of stem, leaves, and bark and screen them on basis of phenolic, flavonoids contents and antioxidant, antibacterial, lipoxygenase and tyrosinase inhibition activities. Furthermore, cytocompatibility of the extract was also determined prior starting in vivo investigations. Then the in vivo performance of 2% bark extract loaded emulsion formulation was determined by using non-invasive probe cutometer and elastometer with comparison to base formulation. The preliminary experiment showed that bark extract has a significant amount of phenolic and flavonoid compounds with eminent antioxidant potential. Furthermore, indicated an efficient antibacterial, lipoxygenase, and tyrosinase enzyme inhibition activities. Importantly, the bark extract did not induce any toxicity or apoptosis, when incubated with HaCat cells. Moreover, the in vivo results showed the formulation (size 3 μm) decreased the skin melanin, erythema and sebum contents up to 2.1-,2.7-and 79%, while increased the skin hydration and elasticity up to 2-folds and 22% as compared to the base, respectively. Owing to enhanced therapeutic effects the phytocosmetic formulation proved to be a potential skin whitening, moisturizer, anti-acne, anti-wrinkle, anti-aging therapy and could actively induce skin rejuvenation and resurfacing.

Keywords: Biocompatibility; Phenolic and flavonoids; Phytocosmetic emulsion; Skin rejuvenation and resurfacing; Tyrosinase inhibition.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Antioxidants / analysis
  • Apoptosis / drug effects
  • Cell Line
  • Cell Shape / drug effects
  • Cosmetics / pharmacology*
  • Drug Compounding*
  • Elasticity
  • Erythema / pathology
  • Flavonoids / analysis
  • Humans
  • Lipoxygenase Inhibitors / pharmacology
  • Male
  • Melanins
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Phenols / analysis
  • Phytochemicals / pharmacology*
  • Plant Bark / chemistry
  • Plant Leaves / chemistry
  • Rheology
  • Sebum / metabolism
  • Skin / pathology
  • Sun Protection Factor

Substances

  • Anti-Bacterial Agents
  • Antioxidants
  • Cosmetics
  • Flavonoids
  • Lipoxygenase Inhibitors
  • Melanins
  • Phenols
  • Phytochemicals
  • Monophenol Monooxygenase